GMAB:NASDAQ
Genmab A/S - ADR
$32.47
arrow_upward
+0.74%(+0.24) 1D
$32.51
arrow_upward
+0.12% (+0.040)bedtimeAfter hours
Closed: Sep 11, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GMAB...
Open
$32.45
High
$32.70
Low
$32.27
Mkt. cap
20.37B
Avg. vol.
2.48M
Volume
1.39M
P/E ratio
25.58
52-wk high
$35.43
52-wk low
$23.62
EPS
$1.27
Beta
0.84
Shares outstanding
623.78M
No. of employees
3K
Open
$32.45
High
$32.70
Low
$32.27
Mkt. cap
20.37B
Avg. vol.
2.48M
Volume
1.39M
P/E ratio
25.58
52-wk high
$35.43
52-wk low
$23.62
EPS
$1.27
Beta
0.84
Shares outstanding
623.78M
No. of employees
3K
News stories
From web sources and news partners
Stock Traders Daily
·
1 day ago
The Technical Signals Behind (GMAB) That Institutions Follow
ad-hoc-news.de
·
2 days ago
Genmab stock gains as capital increase and updated Articles of Association support growth plans
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S - ADR
CEOJan G. J. van de Winkel
Employees3.12K
Founded1999
Headquarters-
SectorBiotechnology
Websitegenmab.com